|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss for the period to net cash used in operating activities: | |||||
| Non-cash portion of interest expense – Note 9 | |||||
| Non-cash interest expense, including accelerated amortization of original issue discount and issuance costs | |||||
| Depreciation and amortization | |||||
| Miscellaneous loss | |||||
| Gain on settlement of accounts payable | |||||
| Stock-based compensation costs | |||||
| Accretion – Note 8 | |||||
| Asset retirement obligation adjustments – Note 13 | |||||
| Impairment charges and write-downs – Notes 4, 5, and 7 | |||||
| Loss on sale of equipment | |||||
| Non-cash (gain) loss on fair value adjustment for warrant liabilities – Notes 14 and 21 | |||||
| Other non-cash items | |||||
| Realized loss on sale of equity investment securities | |||||
| Gain on sale of assets, net | |||||
| Gain on settlement of accrued liability | |||||
| Asset retirement obligation adjustments and accretion expense | |||||
| Unrealized gain on equity investment securities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Contract liabilities – Note 11 | |||||
| Receivables, net | |||||
| Accounts payable, accrued expenses, and other liabilities | |||||
| Production-related inventories | |||||
| Other liabilities – Note 12 | |||||
| Prepaids and deposits | |||||
| Supplies inventories, net | |||||
| Interest receivable | |||||
| Payments for asset retirement obligations | |||||
| Receivables | |||||
| Cash settlement of paid-in-kind interest | |||||
| Net cash (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of assets | |||||
| Additions to property, plant, and equipment | |||||
| Proceeds from assets held for sale, net of commissions expense – Note 7 | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments on debt | |||||
| Principal payments on finance leases | |||||
| Repayments of long-term debt | |||||
| Total repayments of long-term debt | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Principal payments | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Reconciliation of cash, cash equivalents, and restricted cash: | |||||
| Cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...